MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
112 hedge funds and large institutions have $1.48B invested in Mirati Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 48 increasing their positions, 31 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
10% less funds holding
Funds holding: 125 → 112 (-13)
38% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 32
Holders
112
Holding in Top 10
7
Calls
$5.9M
Puts
$2.85M
Top Buyers
| 1 | +$27.5M | |
| 2 | +$20.1M | |
| 3 | +$18M | |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$16.2M |
| 5 |
O
OppenheimerFunds
New York
|
+$12.4M |
Top Sellers
| 1 | -$15.3M | |
| 2 | -$11.4M | |
| 3 | -$10.1M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$9.6M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$6.84M |